Overview
GGA Corp.
?
Han Tung Chang
See more contacts
Other Financial Investment Activities
,
Scientific Research and Development Services
,
Securities, Commodity Contracts, and Other Financial Investments and Related Activities
,
Finance and Insurance
,
Investment advice
See All Industries Biological research
See Fewer Industries
See All Industries Biological research
See Fewer Industries
Activities Related to Credit Intermediation
,
Agencies, Brokerages, and Other Insurance Related Activities
,
Depository Credit Intermediation
,
Insurance Carriers
,
Insurance and Employee Benefit Funds
,
Monetary Authorities-Central Bank
,
Nondepository Credit Intermediation
,
Other Investment Pools and Funds
View more , Securities and Commodity Contracts Intermediation and Brokerage Securities and Commodity Exchanges
View fewer
View more , Securities and Commodity Contracts Intermediation and Brokerage Securities and Commodity Exchanges
View fewer
?
?
?
Actual
?
Actual
$20.38 million
Actual
11.71%
91.49%
$724
DEC
?
?
GreTai:4160
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$20.38 million
USD
Actual
1 USD = 32.4834 TWD
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $3 | $2 | $2 |
| Net Investing Cash | -$2 | -$0 | -$2 |
| Net Financing Cash | -$1 | $0 | -$0 |
| Net Change in Cash | $0 | $2 | -$1 |
| Cash at Beginning of Period | $4 | $2 | $3 |
| Cash at End of Period | $4 | $4 | $2 |
| Capital Expenditure | -$1 | -$0 | -$0 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $4 | $4 | $2 |
| Accounts Receivable | $3 | $3 | $3 |
| Inventories | $1 | $1 | $1 |
| Other Current Assets | $9 | $6 | $7 |
| Asset Summary | |||
| Total Current Assets | $17 | $14 | $12 |
| Tangible Fixed Assets | $2 | $1 | $1 |
| Intangible Assets | $ | $ | $ |
| Total Assets | $724 | $595 | $456 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $1 | $1 | $1 |
| Short-Term Debt | $1 | $1 | $0 |
| Other Current Liabilities | $3 | $2 | $2 |
| Liability Summary | |||
| Total Current Liabilities | $5 | $5 | $3 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $5 | $5 | $3 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $8 | $8 | $7 |
| Retained Earnings | $3 | $1 | $1 |
| Equity Summary | |||
| Total Equity | $17 | $13 | $11 |
| Shares Outstanding | 26,690,332 | 26,690,332 | 26,690,316 |